Indonesia Receives 1.1 Million Doses of AstraZeneca Vaccine

The Jakarta Globe
March 8, 2021 | 6:41 pm
SHARE
Boxes containing AstraZeneca vaccine arrive at Soekarno-Hatta Airport in Tangerang, Banten, on March 8,. 2021. Indonesia receives 1.1 million doses of vaccine through Covax in this first delivery.
Boxes containing AstraZeneca vaccine arrive at Soekarno-Hatta Airport in Tangerang, Banten, on March 8,. 2021. Indonesia receives 1.1 million doses of vaccine through Covax in this first delivery.

Jakarta. Indonesia received 1.1 million doses of AstraZeneca’s Covid-19 vaccine from the global vaccine procurement program Covax on Monday afternoon.

Indonesia is among developing countries entitled for free vaccine supply under the UN-backed scheme.

It was the first Covid-19 vaccine other than China’s Sinovac vaccine to arrive in the country, which has administered more than 3.3 million doses since mass inoculation drive against coronavirus began on Jan. 13.

Foreign Minister Retno Marsudi said the government has lobbied for vaccine through the global scheme since October last year.

Advertisement

 “The vaccine that we just received is the initial delivery from the first batch of vaccine assistance through this multilateral scheme. Indonesia will receive a total of 11,704,800 doses of vaccine throughout the first batch,” said Retno, who co-chairs the advanced market commitment engagement group at Covax.

She told a news conference at the airport that first batch deliveries will continue until May.

“Indonesia fully supports the principle of equal access to vaccine for all,” Retno said.

Indonesia is currently in the second stage of vaccination drive targeting essential workers and elderly citizens. The first rollout of the vaccine targeting 1.4 million health workers has been completed late last month.

The government has been aggressively procuring Covid-19 vaccine since six months ago and already reached supply deals on more than 300 million doses with various sources.

Sinovac has agreed to supply 125 million doses of vaccine, a vast majority of which will be produced by Indonesia’s state-run pharmaceutical company Bio Farma.

Indonesia also bought 50 million doses of vaccine from Pfizer-BioNTech.

Tags: Keywords:
SHARE

Related Articles


News Feb 6, 2025 | 11:13 am

Argentina Joins US in Exiting WHO, Citing "Profound Differences"

Argentina's president has ordered the country to withdraw from the World Health Organization (WHO) due to "profound differences".
News Jan 14, 2025 | 5:27 pm

HMPV vs. Covid-19: Key Differences in Risks, Transmission, and Management

Discover the facts about Human Metapneumovirus (HMPV), its transmission, fatality risks, and how it compares to Covid-19.

The Latest


Tech 13 hours ago

Like It or Not, This Button Shaped the Digital Age

The Like button reshaped how we connect, post, and feel online. Its impact is bigger than you think.
Business 14 hours ago

Joining OECD Could Help Indonesia’s Trade Talks with the US, Minister Says

Indonesia to submit OECD accession document in June, aligning the process with US trade talks.
News 14 hours ago

Indonesia Sends Minister Muhaimin to Vatican for Pope Leo XIV's Inauguration

Cak Imin departs for Vatican to attend Pope Leo XIV’s inauguration on Sunday as President Prabowo’s official representative.
News 14 hours ago

Indonesia, China Eye Stronger Strategic Partnership at 75th Anniversary

President Prabowo met China’s envoy to discuss stronger ties as both countries mark 75 years of diplomatic relations.
Business 15 hours ago

Indonesia Reopens Salt Imports as Industries Face Raw Material Shortage

Indonesia delays salt import ban to 2027 as key industries face shortages, allowing time to boost local production.
COPYRIGHT © 2025 JAKARTA GLOBE. ALL RIGHTS RESERVED